This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Baumrucker, S. Search for Related Content PubMed PubMed Citation Articles by Baumrucker, S. Social Bookmarking                         What's this?

Palliation of painful bone metastases: Strontium-89

Housecall Hospice of Upper East Tennessee; Assistant Clinical Professor, East Tennessee State University, College of Medicine, Rogersville, Tennessee

Most patients with bony metastases experience painful symptoms. Strontium-89 isotope therapy is an alternative to traditional hemibody radiation in cases of multiple, diffuse metastases. Generally given as a single IV slow-push infusion, relief begins in one to three weeks, peaks at six weeks, and has a mean duration of 12 months. Up to 22 percent of patients are pain-free at three months.

American Journal of Hospice and Palliative Medicine®, Vol. 15, No. 2, 113-115 (1998)
DOI: 10.1177/104990919801500210


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?